NCI, National Clinical Trials Network Lead Academic Participating Site (LAPS) UG1

NCI，国家临床试验网络牵头学术参与站点 (LAPS) UG1

• 批准号: 9914075
• 负责人: STEVEN R ALBERTS
• 金额: $ 98.4万
• 依托单位: MAYO CLINIC ROCHESTER
• 依托单位国家: 美国
• 财政年份: 2019
• 资助国家: 美国
• 起止时间: 2019-04-12 至 2025-02-28
• 项目状态: 未结题
• 来源: https://reporter.nih.gov/project-details/9914075
• 关键词: Advocate; American College of Radiology Imaging Network; Applications Grants; Arizona; Awareness; Cancer Patient; Cancer Science; Catchment Area; Clinic; Clinical Research; Clinical Trials; Clinical Trials Network; Collaborations; Conduct Clinical Trials; Data; Development; Discipline; Disease; Eastern Cooperative Oncology Group; Ensure; Ethnic Origin; Florida; Focus Groups; Funding; Grant; Gynecologic Oncology Group; Individual; Institution; International; Journals; Lead; Leadership; Malignant Neoplasms; Mayo Clinic Cancer Center; Mentors; Methods; Minnesota; Minority; Minority Enrollment; Monitor; National Clinical Trials Network; National Surgical Adjuvant Breast and Bowel Project; North Central Cancer Treatment Group; Outcome; Participant; Patient Care; Patients; Physicians; Population; Publications; Publishing; Research; Research Personnel; Role; Rural; Rural Population; Site; Strategic Planning; Underserved Population; Universities; cancer care; cancer clinical trial; cancer risk; clinical trial enrollment; cognitive computing; health disparity; innovation; meetings; member; named group; programs; recruit; socioeconomics; success

PROJECT SUMMARY As reflected in this application, Mayo Clinic has a long tradition of clinical research and has been a supporter and active participant in the National Clinical Trials Network (NCTN). Support of the NCTN includes formation of one of the founding organizations (North Central Cancer Treatment Group, now Alliance), Sustained leadership roles in the NCTN and in clinical trials, as well as active supporters of clinical trials. Multiple Mayo Clinic staff continue in current leadership roles within the NCTN or NCI sponsored activities related to the NCTN. Mayo Clinic remains committed to making NCTN trials a prominent part of its portfolio of clinical trials for cancer patients or patients at-risk for cancer. This commitment is reflected in the prioritization of NCTN trials over many other trials, the level of accrual to NCTN trials, further refinements to the activation and monitoring of progress of NCTN trials to ensure their success, the continued leadership role of Mayo Clinic physicians in the NCTN member organizations, and an on-going commitment of the MCCC to support this activity. Mayo Clinic physicians and researchers continue to have an active role in not only patient accrual to NCTN clinical trials, but to leadership in developing and leading trials. Mayo Clinic researchers also continue to be active in presenting the results of these trials at national and international meetings and high-impact journals, as described within the current grant application. Mayo Clinic researchers have continued to be active in performing subsequent analyses of the collected data, and meaningful use of the biospecimens collected from the trials to transform the science of cancer care. Mayo Clinic has also continued to focus on the development of junior investigators in the NCTN to ensure the continued active support of NCTN member organizations and the success of NCTN clinical research. Finally, Mayo Clinic is committed to making clinical trials available to all patients, regardless of their racial, ethnicity, or socioeconomic background.

项目摘要 正如本申请所反映的那样，马约诊所具有悠久的临床研究传统， 国家临床试验网络（NCTN）的积极参与者。对NCTN的支持包括组建 北中央癌症治疗小组（North Central Cancer Treatment Group，现为联盟） 在NCTN和临床试验中的领导角色，以及临床试验的积极支持者。多个马约 诊所工作人员继续在NCTN或NCI赞助的活动中担任当前的领导角色， NCTN。马约诊所仍然致力于使NCTN试验成为其临床试验组合的重要组成部分 对于癌症患者或有癌症风险的患者。这一承诺反映在国家技术和贸易网络的优先次序上。 试验超过许多其他试验，NCTN试验的累积水平，对激活的进一步改进， 监测NCTN试验的进展，以确保其成功，马约诊所继续发挥领导作用 NCTN成员组织中的医生，以及MCCC对支持这一点的持续承诺 活动马约诊所的医生和研究人员继续发挥积极作用，不仅在患者增加， NCTN临床试验，但在开发和领导试验的领导。马约诊所的研究人员还继续 积极在国家和国际会议上介绍这些试验的结果， 期刊，如当前补助金申请中所述。马约诊所的研究人员继续积极地 对收集的数据进行后续分析，并对收集的生物标本进行有意义的使用 从这些试验中获得的信息来改变癌症治疗的科学。马约诊所还继续关注 在NCTN中培养初级调查员，以确保NCTN成员的持续积极支持 NCTN临床研究的成功。最后，马约诊所致力于使临床 所有患者都可以进行试验，无论其种族、民族或社会经济背景如何。